Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Utility of Presepsin in Distinguishing Between Sepsis and SIRS (Systemic Inflammatory Response Syndrome): an Exploratory, Prospective Observational Study in Critically Ill Patients

NCT02052895 is registered in ClinicalTrials.gov with Mochida Pharmaceutical Company, Ltd. as lead sponsor.

NCT NCT02052895
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02052895 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Utility of Presepsin in Distinguishing Between Sepsis and SIRS (Systemic Inflammatory Response Syndrome): an Exploratory, Prospective Observational Study in Critically Ill Patients
Lead sponsor
Mochida Pharmaceutical Company, Ltd.
Phase
Observational
Overall status
Completed
Start date
January 31, 2014
Completion date
July 31, 2015
Enrollment
226 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

sepsis, sirs